These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 27023679)
1. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics. Zhou M; Xie L; Yang Z; Zhou J; Xie J J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679 [TBL] [Abstract][Full Text] [Related]
2. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nandakumar M; Nathan C; Rhee KY Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
4. Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site. Shukla R; Shukla H; Tripathi T Tuberculosis (Edinb); 2018 Jan; 108():143-150. PubMed ID: 29523315 [TBL] [Abstract][Full Text] [Related]
5. Insight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase. Shukla H; Kumar V; Singh AK; Singh N; Kashif M; Siddiqi MI; Yasoda Krishnan M; Sohail Akhtar M Biochimie; 2015 Mar; 110():73-80. PubMed ID: 25576828 [TBL] [Abstract][Full Text] [Related]
6. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916. Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages]. Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266 [TBL] [Abstract][Full Text] [Related]
8. Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility. Shukla H; Shukla R; Sonkar A; Pandey T; Tripathi T Sci Rep; 2017 Apr; 7(1):1058. PubMed ID: 28432345 [TBL] [Abstract][Full Text] [Related]
9. Proteome-wide lysine acetylation profiling of the human pathogen Mycobacterium tuberculosis. Xie L; Wang X; Zeng J; Zhou M; Duan X; Li Q; Zhang Z; Luo H; Pang L; Li W; Liao G; Yu X; Li Y; Huang H; Xie J Int J Biochem Cell Biol; 2015 Feb; 59():193-202. PubMed ID: 25456444 [TBL] [Abstract][Full Text] [Related]
10. Active Site Flexibility of Mycobacterium tuberculosis Isocitrate Lyase in Dimer Form. Lee YV; Choi SB; Wahab HA; Choong YS J Chem Inf Model; 2017 Sep; 57(9):2351-2357. PubMed ID: 28820943 [TBL] [Abstract][Full Text] [Related]
11. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary. Lee YV; Wahab HA; Choong YS Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791 [TBL] [Abstract][Full Text] [Related]
12. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis. Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230 [TBL] [Abstract][Full Text] [Related]
13. First succinyl-proteome profiling of extensively drug-resistant Mycobacterium tuberculosis revealed involvement of succinylation in cellular physiology. Xie L; Liu W; Li Q; Chen S; Xu M; Huang Q; Zeng J; Zhou M; Xie J J Proteome Res; 2015 Jan; 14(1):107-19. PubMed ID: 25363132 [TBL] [Abstract][Full Text] [Related]
14. Alterations in conformational topology and interaction dynamics caused by L418A mutation leads to activity loss of Mycobacterium tuberculosis isocitrate lyase. Shukla H; Shukla R; Sonkar A; Tripathi T Biochem Biophys Res Commun; 2017 Aug; 490(2):276-282. PubMed ID: 28610921 [TBL] [Abstract][Full Text] [Related]
15. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
17. [Molecular cloning, expression, purification and properties of isocitrate lyase gene from Mycobacterium tuberculosis H37Rv]. Hao F; Pei XY; Zhang XL; Zhang SB; Lai XH; Wang HH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Dec; 28(12):845-8. PubMed ID: 16409788 [TBL] [Abstract][Full Text] [Related]
18. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages. Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909 [TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis isocitrate lyase (MtbIcl): role of divalent cations in modulation of functional and structural properties. Kumar R; Bhakuni V Proteins; 2008 Aug; 72(3):892-900. PubMed ID: 18275086 [TBL] [Abstract][Full Text] [Related]
20. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof]. Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]